HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Methanol → 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

HRID 133617
Print

Reaction equation

HRID 133617 reaction equation
C(OC([NH:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)=[O:16])=[O:12])=O)(C)(C)C.BrC[C:33]1[CH:41]=[CH:40][C:36]2=[N:37][O:38][N:39]=[C:35]2[CH:34]=1.C1CCNCC1.CO>C(Cl)(Cl)Cl.C(#N)C>[NH2:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:20][CH2:21][N:22]([C:33]2[CH:41]=[CH:40][C:36]3=[N:37][O:38][N:39]=[C:35]3[CH:34]=2)[CH2:23][CH2:24]1)=[O:16])=[O:12]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

7

Reactant 4

HCID 887MethanolHCID 8082PiperidineHCID 27355875-(Bromomethyl)-2,1,3-benzoxadiazoleHCID 184262024-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine

Product 1

HCID 184262184-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

Reagents, catalysts & solvents

2
HCID 6212ChloroformSolventHCID 6342AcetonitrileSolvent

Procedure

A mixture of 4-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine (0.050 mmol) with 5-(bromomethyl)benzo[c]furazan (0.75 mL), a (piperidinomethyl)polystyrene (2.6-2.8 mmol/g, 60 mg, 0.15 mmol), methanol (0.2 mL), acetonitrile (1.0 mL) and chloroform (0.50 mL) was stirred at 50° C. overnight, cooled to room temperature, loaded onto a Varian™ SCX column and washed with methanol (5 mL×2). The obtained crude product was eluted with a 2 M methanol solution of NH3 (5 mL) and concentrated. Chloroform (1.5 mL) and phenyl isocyanate (0.075 mL) were added to the residue, and the resulting mixture was stirred at room temperature for 1 hour, loaded onto a Varian™ SCX column and washed with methanol (5 mLX 2). The obtained crude product was eluted with a 2 M methanol solution of NH3 (5 mL) and concentrated. The resulting residue was dissolved in methanol (1 mL), and a 4 M dioxane solution of HCl (0.50 ml) was added to the obtained solution. The resulting mixture was stirred at room temperature overnight and concentrated. The residue was then dissolved in methanol, loaded onto a Varian™ SCX column, washed with methanol (5 mL×2), eluted with a 2 M methanol solution of NH3 (5 mL), concentrated and then purified by preparative TLC (SiO2, ethyl acetate/methanol=5:1) to provide 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine (Compd. No. 2130) (3.6 mg, 16%). The purity was determined by RPLC/MS (87%). ESI/MS m/e 459.3 (M++H, C22H24F2N6O3).

Workup

  1. washwashed with methanol (5 mL×2)
  2. customThe obtained crude product
  3. washwas eluted with a 2 M methanol solution of NH3 (5 mL)
  4. concentrationconcentrated
  5. additionChloroform (1.5 mL) and phenyl isocyanate (0.075 mL) were added to the residue
  6. washwashed with methanol (5 mLX 2)
  7. customThe obtained crude product
  8. washwas eluted with a 2 M methanol solution of NH3 (5 mL)
  9. concentrationconcentrated
  10. dissolutionThe resulting residue was dissolved in methanol (1 mL)
  11. additiona 4 M dioxane solution of HCl (0.50 ml) was added to the obtained solution
  12. stirringThe resulting mixture was stirred at room temperature overnight
  13. concentrationconcentrated
  14. dissolutionThe residue was then dissolved in methanol
  15. washwashed with methanol (5 mL×2)
  16. washeluted with a 2 M methanol solution of NH3 (5 mL)
  17. concentrationconcentrated
  18. custompurified by preparative TLC (SiO2, ethyl acetate/methanol=5:1)

Sources & evidence

ORD record
ord-5b3302665e2c4ebfba48b670de53180f
Source dataset
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07390830B1

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes